X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (210) 210
female (130) 130
male (124) 124
oncology (117) 117
middle aged (116) 116
melanoma (115) 115
aged (95) 95
dermatology (89) 89
adult (84) 84
cancer (61) 61
melanoma - drug therapy (59) 59
skin neoplasms - pathology (51) 51
skin neoplasms - drug therapy (46) 46
ipilimumab (45) 45
treatment outcome (45) 45
survival (44) 44
aged, 80 and over (43) 43
metastatic melanoma (41) 41
metastasis (40) 40
immunotherapy (38) 38
care and treatment (36) 36
melanoma - pathology (32) 32
retrospective studies (32) 32
chemotherapy (31) 31
melanoma - genetics (31) 31
mutation (31) 31
risk factors (31) 31
patients (30) 30
research (30) 30
clinical trials (29) 29
prognosis (29) 29
therapy (29) 29
antineoplastic agents - therapeutic use (27) 27
medicine, research & experimental (27) 27
immunology (26) 26
life sciences (26) 26
analysis (25) 25
skin neoplasms - genetics (25) 25
metastases (24) 24
antibodies, monoclonal - adverse effects (23) 23
vemurafenib (23) 23
follow-up studies (22) 22
abridged index medicus (21) 21
adolescent (21) 21
melanoma - mortality (21) 21
young adult (21) 21
antibodies, monoclonal - therapeutic use (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
drug therapy (20) 20
skin (20) 20
tumors (20) 20
diagnosis (19) 19
antineoplastic agents - adverse effects (18) 18
cutaneous melanoma (18) 18
hematology, oncology and palliative medicine (18) 18
neoplasm staging (18) 18
pembrolizumab (18) 18
health aspects (17) 17
medicine, general & internal (17) 17
melanoma - secondary (17) 17
nivolumab (17) 17
skin cancer (17) 17
skin neoplasms - mortality (17) 17
skin neoplasms - therapy (17) 17
disease-free survival (16) 16
immunohistochemistry (16) 16
open-label (16) 16
proto-oncogene proteins b-raf - genetics (16) 16
animals (15) 15
disease progression (15) 15
double-blind method (15) 15
kaposi's sarcoma (15) 15
mutations (15) 15
sarcoma, kaposi - virology (15) 15
skin neoplasms - diagnosis (15) 15
survival rate (15) 15
time factors (15) 15
braf (14) 14
dabrafenib (14) 14
malignant-melanoma (14) 14
prospective studies (14) 14
surgery (14) 14
advanced melanoma (13) 13
cell line, tumor (13) 13
development and progression (13) 13
expression (13) 13
france - epidemiology (13) 13
medical research (13) 13
multicenter (13) 13
studies (13) 13
biochemistry (12) 12
biopsy (12) 12
dacarbazine (12) 12
mice (12) 12
patient outcomes (12) 12
quality of life (12) 12
sarcoma (12) 12
sarcoma, kaposi - pathology (12) 12
squamous cell carcinoma (12) 12
survival analysis (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 611 - 622
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 863 - 873
Summary Background Dabrafenib plus trametinib improves clinical outcomes in BRAFV600 -mutant metastatic melanoma without brain metastases; however, the... 
Hematology, Oncology and Palliative Medicine
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 2018, Volume 6, Issue 1, pp. 7 - 7
Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer associated with poor survival outcomes in patients with distant metastatic disease... 
Avelumab | Javelin | Pd-L1 | Merkel cell carcinoma | ONCOLOGY | PROGNOSIS | OUTCOMES | IMMUNOLOGY | CHEMOTHERAPY | Chemotherapy | Usage | Care and treatment | Analysis | Clinical trials | Development and progression | Metastasis | Research | Skin cancer | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 19, pp. 1845 - 1855
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 16, pp. 1535 - 1546
Journal Article
Cancer immunology, immunotherapy, ISSN 1432-0851, 2019, Volume 68, Issue 4, pp. 609 - 618
Journal Article
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 71, Issue 5, pp. 926 - 934
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 323 - 332
Summary Background In the BRIM-3 trial, vemurafenib was associated with risk reduction versus dacarbazine of both death and progression in patients with... 
Hematology, Oncology and Palliative Medicine
Journal Article